Red clover isoflavones,
does it really help with Relief of menopausal hot flashes and night sweats?
research showsThe large 252-person ICE trial and Cochrane pooling found no benefit over placebo for red clover isoflavones, whereas a 2026 meta-analysis reported a modest reduction in hot-flash frequency (SMD −0.446). The conflict between a null large trial and earlier synthesis and a modestly positive recent meta-analysis supports C.
ads claimAdvertisements use phrases such as 'plant estrogen,' 'solves heat and cold sweats,' and 'hormone balance.' Actual results differ by formulation and, even when an average effect is present, represent a modest change in hot-flash frequency.
Useful facts when choosing a product
- Trial doses ranged widely, from about 37.1 to 160 mg/day of total isoflavones.
- Promensil and Rimostil are standardized formulations with different isoflavone amounts and compositions.
- Hot-flash diaries and menopause symptom scales were the main endpoints.
- Short-term adverse events were similar to placebo, but long-term safety and safety in hormone-sensitive conditions are not adequately established.
What the research actually shows
The Tice 2003 ICE trial assigned 252 women to Promensil 82 mg, Rimostil 57 mg, or placebo for 12 weeks and found similar reductions in hot flashes. In the Lethaby 2013 Cochrane review, the difference across five Promensil trials was nonsignificant. Jiang 2026 reported a small-to-moderate effect across nine RCTs, but doses ranged from 37.1 to 160 mg and durations from 12 weeks to 12 months, with differing formulations.
Why this is classified as C (48)
The large 252-person ICE trial and Cochrane pooling were null, while the 2026 meta-analysis was modestly positive at SMD −0.446. The direction does not converge and formulations and doses are heterogeneous, resulting in C with 48 points.
Counterpoint. A small effect remains possible for particular higher-dose standardized formulations and people with frequent symptoms. This judgment applies to the product class on average.
Rejudgment record. Reassessment (cross-check reflected) — A null large 252-person ICE trial and Cochrane pooling conflict with a modestly positive 2026 meta-analysis (SMD −0.446), supporting C
Cross-check — Codex and Claude
Evidence Table
| Study | Design | Sample | Funding | Endpoint | Result | Weight |
|---|---|---|---|---|---|---|
| Tice JA et al. 2003 | Multicenter randomized double-blind placebo-controlled trial | 252 | Linked to Novogen products and support | Daily hot-flash frequency and quality of life over 12 weeks | Reductions were similar with Promensil, Rimostil, and placebo, with no clinically important difference. | Decisive |
| Lethaby A et al. 2013 | Cochrane systematic review | 5 | Independent academic review | Hot-flash frequency and menopausal vasomotor symptoms | Promensil versus placebo was nonsignificant, MD -0.93/day (95% CI -1.95 to 0.10). | Key |
| Jiang W, Wu K. 2026 | GRADE-assessed systematic review and meta-analysis | 9 | No conflicts reported | Hot-flash frequency and severity | Reported a small-to-moderate reduction in frequency, SMD -0.446 (95% CI -0.807 to -0.084). | Key |
Receipt — 3 References
All 3 cited sources were verified for existence at the original page (as of 2026-07-11).
Reviewed and approved: Chamgap Editorial Team · Approval date: 2026-07-11 · Corrections: none
Cite this verdict
[Chamgap] Red clover isoflavones x relief of menopausal hot flashes and night sweats — Evidence Grade C·48. 3 cited sources checked. Source: https://health-receipt.pages.dev/en/verdicts/womens/red-clover-hot-flashes-night-sweats/ · CC BY 4.0CC BY 4.0 — free to use with attribution; do not distort grades, numbers, or verdict meaning.
What this document does and does not do
Chamgap is an information source. It reports what research has and has not confirmed; it does not tell readers what to take or buy. That decision belongs to readers and, when needed, medical or legal professionals. This verdict reflects literature available up to the search date and may change as new research appears. Nothing here is medical advice.